Hypoglycemic Agents: all 3,927 studies that test it
Page 28 of 40. Open to participants first (294), then studies with results posted, then the rest; newest registration first within each.
- Efficacy of Repaglinide in Subjects With Type 2 DiabetesCompletedNCT01698931Phase 4
- Comparison of Two Insulin Aspart Formulations in Healthy VolunteersCompletedNCT01698697Phase 1
- Frequency of Hypoglycaemic Episodes During Treatment With Insulin Detemir in Well Controlled Subjects With Type 1 DiabetesCompletedNCT01697657Phase 3
- Glycemic Control of Biphasic Insulin Aspart 30 in Type 2 DiabetesCompletedNCT01697631Phase 4
- Pharmacokinetics, Pharmacodynamics and Safety of Biphasic Insulin Aspart 30 in Type 2 DiabetesCompletedNCT01697618Phase 2
- Assessing the Impact of Pioglitazone on Skin Barrier Function in Atopic Dermatitis PatientsWithdrawnNCT01695707Not applicable
- Study to Compare Between Combimed Metformin-letrozole and Ovarian Drilling in Pcos With Bilateral Ovarian Drilling in Clomiphene-resistant Infertile Women With Polycystic Ovarian SyndromeCompletedNCT01693289Phase 1
- A Study of Aleglitazar in Combination With Metformin in Patients With Type 2 Diabetes Mellitus Who Are Inadequately Controlled With Metformin AloneCompletedNCT01691846Phase 3
- Comparison of a New Formulation of Insulin Glargine With Lantus® Both in Combination With Oral Antihyperglycemic Drug(s) in Japanese Patients With Type 2 Diabetes MellitusCompletedNCT01689142Phase 3
- Comparison of a New Formulation of Insulin Glargine With Lantus® in Japanese Patients With Type 1 Diabetes MellitusCompletedNCT01689129Phase 3
- A Double-blind, Parallel Group, Comparative Study of Coadministration AD-4833 and SYR-322CompletedNCT01686711Phase 4
- Improving the Treatment for Women With Early Stage Cancer of the UterusActive, not recruitingNCT01686126Phase 2
- Metformin for the Treatment of Endometrial HyperplasiaCompletedNCT01685762Early Phase 1
- A Randomised Trial Evaluating Continuous Subcutaneous Infusion of Formulations of NN1218 and NovoLog® in Subjects With Type 1 DiabetesCompletedNCT01682902Phase 1
- Effect of Genetic Variants in MATE1 and OCT3 on the Pharmacodynamics of Metformin in African AmericansCompletedNCT01681693Phase 1
- Effect of Anti-diabetic Drugs on Bone Metabolism and Glycemic VariabilityCompletedNCT01679899Phase 4
- Insulin Glulisine and Aspart in Postprandial Glycemic Control After High-GI Meal in Children With Type 1 Diabetes MellitusCompletedNCT01678235Phase 4
- Obesity in Children and Adolescents: Associated Risks and Early InterventionCompletedNCT01677923Phase 3
- Impact of the Addition of Metformin to Abiraterone in Metastatic Prostate Cancer PatientsCompletedNCT01677897Phase 2
- Bioequivalence Study of 4 mg Glimepiride TabletCompletedNCT01677247Not applicable
- Repeated Dose Study With a New Insulin Glargine Formulation and Lantus® on 24-hour Glucose Profile in Japanese Patients With Type 1 Diabetes MellitusCompletedNCT01676233Phase 1
- Medical Nutrition Therapy Plus Transgestational Metformin For Preventing Gestational Diabetes In High Risk Mexican WomenCompletedNCT01675310Phase 4
- Mechanisms of Improved Wound Healing and Protein Synthesis of Insulin and MetforminTerminatedNCT01666665Phase 2/3
- Effects of Metformin, Pegylated Interferon Alpha and Ribavirin for Chronic Hepatitis C With Insulin ResistanceStatus unknownNCT01664845Phase 2/3
- Comparator Trial Using Insulin Glulisine vs. Insulin Lispro for Treatment of Gestational DiabetesCompletedNCT01662921Phase 2
- BE Study of the Combinations of Gemigliptin 50mg and Metformin HCl Extended Release 1000mg in Comparison to Each Component Administered AloneCompletedNCT01662674Phase 1
- Study of Comparing the Different Effect of DPP-4 Inhibitors and Sulfonylurea by Using "Biphase-Hyperglycemic Clamp"Status unknownNCT01660386Phase 4
- Phase 2b Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group Study to Assess the PD Response and Safety of Three Dose Levels of (PB1023) Injection Following 20 Weeks of Weekly SC Dosing in Adults With T2DMCompletedNCT01658501Phase 2
- The Impact of Gall Bladder Emptying and Bile Acids on the Human GLP-1-secretionCompletedNCT01656057Not applicable
- The Effect of Metformin on Obesity and Metabolic Disturbance in Patients Taking ClozapineTerminatedNCT01654640Phase 4
- Study of Erlotinib and Metformin in Triple Negative Breast CancerCompletedNCT01650506Phase 1
- Effects of Siliphos-Selenium-Methionine-Alpha Lipoic Acid in Patients With Fatty Liver and Non-alcoholic SteatohepatitisCompletedNCT01650181Phase 4
- Safety and Efficacy of Biphasic Insulin Aspart 50 in Subjects With Type 2 DiabetesCompletedNCT01650129Phase 3
- Safety and Efficacy of Insulin Aspart in Type 2 DiabetesCompletedNCT01649570Phase 4
- Safety and Efficacy of Vildagliptin Versus NPH Insulin add-on to Glimepiride in Type 2 Diabetes Mellitus Patients.CompletedNCT01649466Phase 4
- Insulin Therapy for Post-transplant Glucocorticoid Induced HyperglycemiaTerminatedNCT01648218Phase 4
- Treatment With Sitagliptin in Non-obese Japanese Patients With Type 2 Diabetes MellitusStatus unknownNCT01642108Not applicable
- Clomifene Citrate Versus Metformin in First-line Treatment of Infertility in Patients With Polycystic Ovary Syndrome and a Resistance to InsulinWithdrawnNCT01638988Phase 3
- Efficacy of Pulsatile IV Insulin on Cognition and Amyloid Burden in Patients With Alzheimer's DiseaseWithdrawnNCT01636596Not applicable
- Comparison of Hypoglycaemic Regimens During Ramadan Fasting in Type 2 DiabetesCompletedNCT01624116Not applicable
- Bioequivalence of Two Formulations of Biphasic Insulin Aspart 50 in Japanese SubjectsCompletedNCT01620437Phase 1
- Pharmacokinetics and Pharmacodynamics of Biphasic Insulin Aspart 30 and 50 in Subjects With Type 2 DiabetesCompletedNCT01620424Phase 1
- Pharmacokinetics of Biphasic Insulin Aspart 50 and 70 in Japanese Healthy VolunteersCompletedNCT01620333Phase 1
- Clinical Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LEZ763CompletedNCT01619332Phase 1/2
- A Trial Investigating the Pharmacodynamic Properties of NN1218 in Subjects With Type 1 DiabetesCompletedNCT01618188Phase 1
- Rapid Effects Linagliptin on Monocyte Polarization and Endothelial Progenitor Cells in Type 2 DiabetesCompletedNCT01617824Phase 4
- Metformin-Dipyridamole Interaction TrialCompletedNCT01613755Phase 4
- The Metformin-FMD TrialCompletedNCT01610401Phase 4
- A Single Center Study to Evaluate the Efficacy and Safety of ETC 1002 in Subjects With Type 2 DiabetesCompletedNCT01607294Phase 2
- Effect of Repaglinide on Postprandial Lipemia in Type 2 DiabetesCompletedNCT01605773Phase 4
- Effects of Vildagliptin/Metformin Combination on Markers of Atherosclerosis, Thrombosis, and Inflammation in Diabetics With Coronary Artery DiseaseCompletedNCT01604213Phase 4
- BE Study of the Combinations of Gemigliptin 50mg and Metformin HCl Extended Release 500mg in Comparison to Each Component Administered AloneCompletedNCT01595880Phase 1
- Metformin in Pregnancy in Women With Polycystic Ovary SyndromeCompletedNCT01594697Not applicable
- Basal Bolus vs. Sliding Scale for Treatment of Diabetic Patients in Medical WardsCompletedNCT01594060Phase 4
- Comparison of Metformin and Pioglitazone Effects on Adipokines Concentrations in Newly Diagnosed Type 2 Diabetes PatientsCompletedNCT01593371Not applicable
- A Long-term Trial to Compare the Effects of Liraglutide and Sulphonylurea (Glimepiride) Both in Combination With Metformin on Clinical, Endothelial and Image Markers of Cardiovascular Risk in Patients With Type 2 DiabetesWithdrawnNCT01593137Phase 4
- A Trial Investigating the Pharmacodynamic Properties of NN5401 in Subjects With Type 1 DiabetesCompletedNCT01590836Phase 1
- Neoadjuvant Letrozole Plus Metformin vs Letrozole Plus Placebo for ER-positive Postmenopausal Breast CancerCompletedNCT01589367Phase 2
- Effects of Short-term Intensive Insulin Therapy in Newly Diagnosed Type 2 Diabetes PatientsStatus unknownNCT01588743Not applicable
- Metformin to Prevent Late Miscarriage and Preterm Delivery in Women With Polycystic Ovary SyndromeCompletedNCT01587378Not applicable
- Efficacy and Safety of Vildagliptin 50mg Bid as an add-on Therapy to Insulin With or Without Metformin, in Patients With Type 2 Diabetes MellitusCompletedNCT01582230Phase 3
- Effects of Drospirenone-ethinylestradiol and/or Metformin on Cardiovascular Risk in Hyperinsulinemic Women With Polycystic Ovary SyndromeCompletedNCT01581814Phase 3
- Efficacy of Metformin and Diane-35 on PCOS Patients,a Randomized, Controlled, Prospective Clinical TrialCompletedNCT01573377Not applicable
- A Pilot Study Evaluating Safety of Sitagliptin Combined With Peg-IFN Alfa-2a + Ribavirin in Chronic Hepatitis C PatientsTerminatedNCT01567540Phase 1
- Metformin Plus Neoadjuvant Chemotherapy in Breast CancerStatus unknownNCT01566799Phase 2
- Effect of Adding Vildagliptin on Beta Cell Function and Cardiovascular Risk Markers in Patients With Moderate Metabolic Control During Metformin MonotherapyStatus unknownNCT01565096Phase 4
- A Comparison Between Two Oral Hypoglycemics - Metformin and Glybenclamide for the Treatment of Gestational Diabetes MellitusCompletedNCT01563120Phase 4
- Efficacy and Safety of Repaglinide Combined With Insulin NPH in Subjects With Type 2 DiabetesCompletedNCT01562561Phase 3
- Study of Metformin With Simvastatin for Men With Prostate CarcinomaWithdrawnNCT01561482Phase 2
- Evaluation of Vildagliptin (Galvus®) as add-on to Insulin in New-onset Type 1 Diabetes MellitusStatus unknownNCT01559025Phase 3
- A Phase I Study to Assess the Pharmacokinetics of Metformin When Administered Alone and in Combination With VandetanibCompletedNCT01551615Phase 1
- Prospective Trial of Metformin - Chemoprevention RoleWithdrawnNCT01550900Not applicable
- Study of Nasal Insulin to Fight Forgetfulness - Long-acting Insulin Detemir - 21 DaysCompletedNCT01547169Phase 2
- Effect of Linagliptin in Comparison With Glimepiride as Add on to Metformin on Postprandial Beta Cell Function, Postprandial Metabolism and Oxidative Stress in Patients With Type 2 Diabetes MellitusStatus unknownNCT01547104Phase 4
- Single Cohort 4-period Study to Assess Pharmacokinetics of Metformin Alone and in Combination With RanolazineCompletedNCT01546597Phase 1
- Single Cohort, 2-Period Study to Assess Pharmacokinetics of Metformin Alone and in Combination With Ranolazine 500 mgCompletedNCT01546558Phase 1
- Comparison of Technosphere Insulin Inhalation Powder & Subcutaneous Rapid-Acting Analog in Subjects With Type 1 DiabetesCompletedNCT01544881Phase 1
- Nonalcoholic Fatty Liver Disease (NAFLD) Pharmacological Treatment: Metformin Versus AtorvastatinStatus unknownNCT01544751Not applicable
- Pharmacokinetics of Insulin Detemir in Subjects With Type 1 DiabetesCompletedNCT01542450Phase 1
- Efficacy of VIldagliptin aS an Add-on Therapy to Metformin Compared to Metformin Up-TitratION in Chinese Patients With Type 2 Diabetes.(VISION)CompletedNCT01541956Phase 4
- Insulin Profile of Biphasic Insulin Aspart 70 to That of Biphasic Insulin Aspart 30 in Healthy VolunteersCompletedNCT01538511Phase 1
- Comparison of the Pharmacodynamics and Pharmacokinetics of Biphasic Insulin Aspart 30, 50, 70 and Insulin Aspart in Subjects With Type 1 DiabetesCompletedNCT01536028Phase 1
- Bioequivalence of Two Insulin Aspart Formulations (100 U/mL Versus 200 U/mL)CompletedNCT01530048Phase 1
- Temsirolimus in Combination With Metformin in Patients With Advanced CancersTerminatedNCT01529593Phase 1
- Metformin for the Treatment of Unexplained OligozspermiaStatus unknownNCT01529177Phase 4
- Metformin in Children With Relapsed or Refractory Solid TumorsCompletedNCT01528046Phase 1
- Bioequivalence of Two Formulations of Biphasic Insulin Aspart 70 in Healthy SubjectsCompletedNCT01527656Phase 1
- Bioequivalence of Two Formulations of Biphasic Insulin Aspart 50 in Healthy SubjectsCompletedNCT01527643Phase 1
- Bioequivalence of Two Formulations of Biphasic Insulin Aspart 50 in Healthy Japanese SubjectsCompletedNCT01527630Phase 1
- Bioequivalence of Two Formulations of Biphasic Insulin Aspart 70 in Healthy Male SubjectsCompletedNCT01527565Phase 1
- Bioequivalence of Two Formulations of Biphasic Insulin Aspart 50 in Healthy Male SubjectsCompletedNCT01527552Phase 1
- Long Term Safety and Efficacy of Biphasic Insulin Aspart 30 in Subjects With Type 2 DiabetesCompletedNCT01527539Phase 3
- Glycaemic Control of Biphasic Insulin Aspart 70 and 30 in Subjects With Type 2 DiabetesCompletedNCT01526980Phase 2
- Comparison of Single Dose and Steady State Pharmacodynamics of Biphasic Insulin Aspart 30 and 70 in Subjects With Type 1 DiabetesCompletedNCT01526941Phase 1
- Spironolactone Plus Metformin in Polycystic Ovary SyndromeCompletedNCT01526616Not applicable
- Assessment of Blood Glucose Changes in Healthy Volunteers After BMS-754807 Alone or BMS-754807 With MetforminCompletedNCT01525823Phase 1
- Pharmacokinetics of Biphasic Insulin Aspart 30 and 70 in Subjects With Type 1 DiabetesCompletedNCT01524809Phase 1
- Comparison of Two Formulations of Biphasic Insulin Aspart 70CompletedNCT01523041Phase 1
- Study of Combination Therapy With SYR-322CompletedNCT01521962Phase 3
- Metformin Effects on Oxidative Stress Parameters in Newly Diagnosed Type 2 Diabetes PatientsCompletedNCT01521624Not applicable